trimethobenzamide has been researched along with Aganglionic Megacolon in 1 studies
trimethobenzamide: major descriptor (64-84); on-line search BENZAMIDES (64-84); Index Medicus search TRIMETHOBENZAMIDE (64-84); RN given refers to parent cpd
trimethobenzamide : The amide obtained by formal condensation of 3,4,5-trihydroxybenzoic acid with 4-[2-(N,N-dimethylamino)ethoxy]benzylamine. It is used to prevent nausea and vomitting in humans.
Excerpt | Relevance | Reference |
---|---|---|
"Trimethobenzamide (TMB) has a pregnancy category C labeling." | 3.77 | Growth failure, tardive dyskinesia, megacolon development, and hepatic damage in neonatal rats following exposure to trimethobenzamide in utero. ( Gokcimen, A; Goksu Erol, AY; Ozdemir, O, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goksu Erol, AY | 1 |
Gokcimen, A | 1 |
Ozdemir, O | 1 |
1 other study available for trimethobenzamide and Aganglionic Megacolon
Article | Year |
---|---|
Growth failure, tardive dyskinesia, megacolon development, and hepatic damage in neonatal rats following exposure to trimethobenzamide in utero.
Topics: Animals; Animals, Newborn; Antiemetics; Benzamides; Chemical and Drug Induced Liver Injury; Female; | 2011 |